Insulet
PODD
#1133
Rank
C$22.49 B
Marketcap
$320.89
Share price
-0.46%
Change (1 day)
48.95%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): C$0.41 B

According to Insulet's latest financial reports the company's current earnings (TTM) are C$0.41 B. In 2023 the company made an earning of C$0.34 B an increase over its 2022 earnings that were of C$58.46 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.41 B21.36%
2023 C$0.34 B481.9%
2022 C$58.46 M-45.24%
2021 C$0.10 B43.35%
2020 C$74.46 M18.51%
2019 C$62.83 M41.16%
2018 C$44.51 M-711.95%
2017 -C$7.28 M-56.85%
2016 -C$16.86 M-79.31%
2015 -C$81.51 M63.85%
2014 -C$49.75 M31.04%
2013 -C$37.96 M-21.96%
2012 -C$48.65 M
2010 -C$46.4 M-42.38%
2009 -C$80.52 M-33.56%
2008 -C$0.13 B65.93%
2007 -C$73.04 M209.75%
2006 -C$23.58 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.96 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.19 B-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.12 B 169.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.49 B 6,518.67%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.82 B 2,025.04%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.65 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$12.19 B 2,834.80%๐Ÿ‡บ๐Ÿ‡ธ USA